IPO Boutique

Unicycive Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Unicycive Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Unicycive Therapeutics Inc.UNCY -
NASDAQ
$5.00-$6.00 $5.00 $8.555 million7/13/2021
Roth Capital
Co-Manager(s):
Kingswood Capital
Health Care
Filing(s):

Filed 2021-05-21
Terms Added 2021-06-07
Terms Changed 2021-06-21
Terms Changed 2021-06-30



Unicycive Therapeutics Inc. Quote & Chart - Click for current quote - UNCY

About Unicycive Therapeutics Inc. (adapted from Unicycive Therapeutics Inc. prospectus):
They are a biotechnology company dedicated to developing treatments for certain medical conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "UNCY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved